MG
INSM icon

Michael Gelband’s Insmed INSM Stock Holding History

Michael Gelband’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.41M Sell
69,500
-78,633
-53% -$9.52M 0.05% 373
2026
Q1 		$24.2M Buy
148,133
+68,046
+85% +$10.5M 0.19% 74
2025
Q4 		$13.9M Buy
+80,087
New +$14.6M 0.11% 170
2025
Q3 		– Sell
-92,717
Closed -$9.33M – 1764
2025
Q2 		$9.33M Buy
92,717
+4,934
+6% +$377K 0.08% 246
2025
Q1 		$6.7M Buy
+87,783
New +$6.71M 0.07% 321
2024
Q4 		– Sell
-85,183
Closed -$6.22M – 1755
2024
Q3 		$6.22M Buy
85,183
+42,578
+100% +$3.14M 0.04% 347
2024
Q2 		$2.85M Buy
+42,605
New +$1.65M 0.02% 652
2023
Q4 		– Sell
-33,165
Closed -$837K – 1743
2023
Q3 		$837K Buy
+33,165
New +$758K 0.01% 1022
2023
Q1 		– Sell
-75,227
Closed -$1.5M – 1933
2022
Q4 		$1.5M Sell
75,227
-153,307
-67% -$2.96M 0.02% 765
2022
Q3 		$4.92M Buy
228,534
+213,093
+1,380% +$5.11M 0.06% 409
2022
Q2 		$304K Buy
+15,441
New +$324K ﹤0.01% 1530
2021
Q2 		– Sell
-67,008
Closed -$2.28M – 2568
2021
Q1 		$2.28M Buy
67,008
+3,690
+6% +$141K 0.03% 522
2020
Q4 		$2.11M Buy
63,318
+55,132
+673% +$2.01M 0.02% 527
2020
Q3 		$263K Sell
8,186
-5,730
-41% -$165K 0.01% 1344
2020
Q2 		$383K Buy
+13,916
New +$330K 0.01% 1198
2020
Q1 		– Sell
-24,072
Closed -$575K – 1347
2019
Q4 		$575K Buy
24,072
+2,106
+10% +$42.8K 0.01% 790
2019
Q3 		$387K Buy
+21,966
New +$424K 0.01% 771

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Michael Gelband's INSM Position: Q2 2026 in Review

Michael Gelband reduced its Insmed (INSM) stake by 53% in Q2 2026, selling an estimated $9.52M and leaving 69,500 shares worth $7.41M. The position accounts for 0.05% of the portfolio, ranked #373.

Michael Gelband first reported a position in INSM in Q3 2019 and has held it in 17 quarters since. The position peaked at $24.2M in Q1 2026. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Michael Gelband held 69,500 shares of Insmed worth $7.41M as of Q2 2026.
  • Michael Gelband sold 78,633 Insmed shares in Q2 2026, an estimated $9.52M.
  • Insmed made up 0.05% of Michael Gelband's portfolio in Q2 2026, its #373 holding.
  • Michael Gelband first reported a position in Insmed in Q3 2019 and has held it in 17 quarters since.
  • Michael Gelband's Insmed position peaked at $24.2M in Q1 2026.
  • 663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.